ASGCT Career Development Awards

The American Society of Gene and Cell Therapy will award a total of $300,000 in support of members developing their careers.

Applications for the 2020 ASGCT Career Development Awards open on June 1 and close August 1.

ASGCT will award a $50,000 Career Development Award in each of the following six broad topics (6 total grants):

  • Viral Vector Development
  • Gene Targeting and Gene Correction
  • Oligonucleotide Therapeutics
  • Synthetic/Molecular Conjugates and Physical Methods for Delivery of Gene Therapeutics
  • Immunological Aspects of Gene Therapy and Vaccines
  • Cell Therapies

Career Development Award
Overview and Benefits

Career Development Award
Required Documents

The purpose of these awards is to support independent transformative pilot studies in gene and cell therapy by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms. ASGCT is interested in helping applicants generate their own independent preliminary data to use in larger proposals (NIH K awards, first-submission R-level funding, etc.) to gain independence. Learn more about the eligibility requirements, application materials, and key deadlines in the Career Development Award Overview and Benefits.

Frequently Asked Questions

Who Can Apply?

Any ASGCT member type may apply who is in good standing or have a membership application pending. To verify your membership status, please log in to your ASGCT account.

Not an ASGCT member yet? Take the first step. Submit your membership application at least 5 business days prior to the application deadline to allow sufficient time for processing. The mentor is not required to be an ASGCT member.

Show Answer
What can this grant be used for?

Each $50,000 award must be used during the budget period of November 2019 – December 2020. All funds must be used for direct expenses associated with conducting the proposed project, and are non-transferable. It can include personnel and travel where those expenses are directly related to the project. ASGCT considers salary, where it is directly attributed to the sponsored project and meets all other criteria, a direct cost.  Please refer to our Grant Policy Statement for a list of accepted costs.

Show Answer
Is U.S. citizenship a requirement?

U.S. citizenship is not required but both the applicant and mentor must be located in the United States during the duration of the research. Any visa and/or citizenship restrictions applicable to receiving the award are the responsibility of the applicant.

Show Answer
May a mentor support multiple applicants?


Show Answer
Who has previously won these awards?

2018 Awardees

  • Ulrika Beitnere, Ph.D.—University of California Davis, Department of Biochemistry and Molecular Medicine
  • Diana X. Bharucha-Goebel, M.D.—Children’s National Health System and The George Washington University School of Medicine and Health Sciences
  • Lauriel F. Earley, Ph.D.—University of Chapel Hill – North Carolina, Gene Therapy Center, Department of Pediatrics
  • Mohamed A. Hammad, Ph.D.—Beckman Research Institute of the City of Hope
  • Geoffrey D. Keeler—University of Florida, Department of Pediatrics, Division of Cellular & Molecular Therapy
  • Makan Khoshnejad Ph.D.—The Wistar Institute, The Vaccine Center
  • Benjamin Kleinstiver, Ph.D.—Massachusetts General Hospital
  • Ami Patel, Ph.D.—The Wistar Institute, Vaccine and Immunotherapy Center
  • Nicole Paulk, Ph.D.—University of California San Francisco, Department of Biochemistry & Biophysics
  • Sandhya Sharma—Baylor College of Medicine, Center for Cell and Gene Therapy
  • Katie M. Stiles, Ph.D.—Weill Cornell Medical College, Genetic Medicine
  • Lauren E. Woodard, Ph.D.—Vanderbilt University Medical Center, Division of Nephrology and Hypertension, Department of Medicine
  • Mehmet E Yalvac, Ph.D.—The Ohio State University Wexner Medical Center
  • Jiehua Zhou, Ph.D.—Beckman Research Institute of the City of Hope National Medical Center
Show Answer


ASGCT Policy Summit

September 23-25, 2020